C. Duclos

Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response

G. Marit, N. Milpied, R. Tabrizi, 2013, Bone Marrow Transplantation.

Efficacy of Tyrosine Kinase Inhibitors in Ph-like Acute Lymphoblastic Leukemia harboring ABL-class Rearrangements.

J. Soulier, E. Clappier, H. Dombret, 2019, Blood.

Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.

M. Labopin, G. Marit, S. Dimicoli-Salazar, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD.

M. Labopin, G. Marit, F. Mahon, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians.

A. Cimarelli, A. Gessain, C. Casoli, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load.

A. Cimarelli, A. Gessain, C. Casoli, 1996, Virology.